menu
    • menu

    Company profile for Abata Therapeutics

    NEW Drugs in Dev: 2
    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    Munit offers scalable GMP micronization and particle size engineering to enhance drug solubility, bioavailability, and performance.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-04-20

    Virtual Booth

    Contact Supplier

    PMC Isochem is your partner for smart CDMOs of Intermediates, APIs, & excipients & a catalog of Intermediates & Generic APIs.

    Virtual Booth

    Contact Supplier

    Expand your portfolio with Egis- value-added generics, API capabilities, and reliable contract services to drive your growth.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2026-04-20

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Abata Therapeutics is a biotech company focused on translating the biology of regulatory T cells (Tregs) into transformational medicine.We are bringing an entirely new approach to the treatment of autoimmune disease by engineering Tregs as targeted therapies that stop immune-mediated destruction, restore homeostasis – a state of harmony – and promote repair in the affected tissues. In addition to our lead program in progre...
    Abata Therapeutics is a biotech company focused on translating the biology of regulatory T cells (Tregs) into transformational medicine.We are bringing an entirely new approach to the treatment of autoimmune disease by engineering Tregs as targeted therapies that stop immune-mediated destruction, restore homeostasis – a state of harmony – and promote repair in the affected tissues. In addition to our lead program in progressive MS, Abata has early programs in Type 1 Diabetes (T1D) and inclusion body myositis (IBM). We bring together industry experts and deeply engaged pioneers in Treg biology, T cell receptor and antigen discovery

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Abata TherapeuticsUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    Cambridge, MA US
    Telephone
    Telephone
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://abatatx.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/abata-therapeutics/about/
    youtube
    YouTube
    Twitter
    Twitter
    https://x.com/AbataTx

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    AMWC Asia-TDAC

    AMWC Asia-TDAC

    Not Confirmed

    envelop Contact Supplier

    AMWC Asia-TDAC

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Abata Therapeutics Appoints Joanne Beck As CTO
    Abata Therapeutics Appoints Joanne Beck As CTO

    16 Sep 2024

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2024/09/16/2946472/0/en/Abata-Therapeutics-Appoints-Joanne-Beck-Ph-D-as-Chief-Technical-Officer.html

    GLOBENEWSWIRE
    16 Sep 2024
    Share Share
    Abata Therapeutics Gets FDA Fast Track For ABA-101 In Multiple Sclerosis
    Abata Therapeutics Gets FDA Fast Track For ABA-101 In Multiple Sclerosis

    22 Aug 2024

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2024/08/22/2934105/0/en/Abata-Therapeutics-Receives-FDA-Fast-Track-Designation-for-ABA-101-for-the-Treatment-of-Progressive-Multiple-Sclerosis.html

    GLOBENEWSWIRE
    22 Aug 2024
    Share Share
    Abata Therapeutics Gets Bristol Myers Investment For Treg Cell Therapy
    Abata Therapeutics Gets Bristol Myers Investment For Treg Cell Therapy

    15 Aug 2024

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2024/08/15/2930788/0/en/Abata-Therapeutics-Announces-Strategic-Investment-from-Bristol-Myers-Squibb-Supporting-Advancement-of-its-Treg-Cell-Therapy-Pipeline-into-Clinical-Development.html

    GLOBENEWSWIRE
    15 Aug 2024
    Share Share
    Abata Therapeutics' IND Cleared For ABA-101 In Multiple Sclerosis
    Abata Therapeutics' IND Cleared For ABA-101 In Multiple Sclerosis

    09 Jul 2024

    // GLOBENEWSWIRE

    https://www.globenewswire.com/en/news-release/2024/07/09/2910147/0/en/Abata-Therapeutics-Announces-FDA-Clearance-of-Investigational-New-Drug-Application-for-Clinical-Evaluation-of-ABA-101-in-Progressive-Multiple-Sclerosis.html

    GLOBENEWSWIRE
    09 Jul 2024
    Share Share
    Abata Therapeutics Announces Second Development Candidate, ABA-201
    Abata Therapeutics Announces Second Development Candidate, ABA-201

    24 Aug 2023

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20230824945846/en

    BUSINESSWIRE
    24 Aug 2023
    Share Share
    Abata Therapeutics to Present at Upcoming Investor and Industry Events in June
    Abata Therapeutics to Present at Upcoming Investor and Industry Events in June

    31 May 2023

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20230531005339/en

    BUSINESSWIRE
    31 May 2023
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search